Roche Tops the Pharmaceutical Innovation Index for the First Time; AstraZeneca Ranks 1st for Its Pipeline

- Major shake-ups in the ranks of the most innovative pharma

LONDON, April 8, 2020 /PRNewswire/ -- The tenth annual Pharmaceutical Innovation Index, released by IDEA Pharma today, sees Roche top the industry for the first time. At the same time, the second Pharmaceutical Invention Index, a ranking of the industry's best pipelines, sees AstraZeneca retain its No 1 position.

https://mma.prnewswire.com/media/1141774/IDEA_Pharma_Infographic.jpg [https://mma.prnewswire.com/media/1141774/IDEA_Pharma_Infographic.jpg]

The Pharmaceutical Invention Index introduces a ranking of the industry's best pipelines, evaluating novelty and meaningful development, across first in class development, breakthrough medicines and more. Defining innovation as "return on invention," the Pharmaceutical Innovation Index measures, scores and celebrates a company's ability to deliver innovation to patients, by objectively evaluating performance based on a rolling five year period (2014-2019), and operates on the simple premise: if you gave the same molecule to two different companies in early phase, which would make the best of it?

Roche's significant rise to No 1 on the Innovation Index can be attributed to multiple clinical data wins, a pair of novel FDA approvals and many path-leading immuno-oncology firsts by the company's PD-L1, Tecentriq. The Innovation Index top 10 includes new players - Vertex, Alexion and Shionogi - as well as a significant rise for Regeneron, suggesting that smaller companies are, more than ever, able to bring their products to patients without a traditional large pharma partner. AstraZeneca's retention of the Invention Index No 1 reveals the success of their relentless focus on pipeline diversity and novelty.

Pharmaceutical Innovation Index 2020




Company Name

2020 Pharmaceutical

Change from 2019
Innovation Index

---



Roche 1 +7

---



AbbVie 2 0

---



Novartis 3 +6

---



Vertex Pharmaceuticals 3
New

---



Eli Lilly 5 -2

---



AstraZeneca 6 +6

---



Alexion Pharmaceuticals 7
New

---



Merck & Co 8 -3

---



Shionogi & Co 9
New

---



Johnson & Johnson 10 +1

---



Regeneron Pharmaceuticals 10 +7

---


Pharmaceutical Invention Index 2020




Companies
2020 Pharmaceutical

Change from 2019
Invention Index

---



AstraZeneca 1 0

---



Bristol-Myers Squibb 2 +4

---



Eli Lilly 3 0

---



Novartis 4 0

---



Gilead Sciences 5 +6

---



Regeneron Pharmaceuticals 6 +1

---



AbbVie 7 -2

---



Merck & Co 7 +8

---



Vertex Pharmaceuticals 9 -4

---



Roche 10 +2

---


Commenting on the index, IDEA Pharma's CEO, Mike Rea said: "There is no gaming the Pharmaceutical Innovation Index -success is achieved by discovering and developing meaningfully great medicines and getting those medicines to market, and to patients. More than ever, we see that excellence is unevenly distributed across the industry - not every company is equally able to realise the value in their pipeline."

For a more in-depth look at this year's Pharmaceutical Innovation Index, details of the methodology and the top 32 companies, visit www.ideapharma.com/pii [http://www.ideapharma.com/pii].

Infographic - https://mma.prnewswire.com/media/1141774/IDEA_Pharma_Infographic.jpg [https://mma.prnewswire.com/media/1141774/IDEA_Pharma_Infographic.jpg]

For more information please contact: Charlie Mason Communications Director IDEA Pharma Tel: +44-(0)1234-756-340 Email: pii@ideapharma.com [mailto:pii@ideapharma.com]

Web site: https://www.ideapharma.com/

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234